Skip to main content

Lobbying activity

Who's lobbying Congress, for whom, and on what, from federal Lobbying Disclosure Act filings. Covers both chambers, synced daily. 272 filings

Top spenders & firms Spend by issue Political contributions Revolving door

  Showing filings that named HR 946. Clear
Clear
Q1
TRAVERE THERAPEUTICS for TRAVERE THERAPEUTICS
1st Quarter (Jan 1 - Mar 31) 2026 · California · House · Senate
Copyright/Patent/Trademark, Health Issues, Pharmacy, Medical/Disease Research/Clinical Labs
View →
Q1
NOVARTIS for NOVARTIS
1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate
Labor Issues/Antitrust/Workplace, Budget/Appropriations, Copyright/Patent/Trademark, Health Issues
View →
Q1
DLA PIPER LLP (US) for BIOTECHNOLOGY INNOVATION ORGANIZATION
1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate · $60,000.00 income
Medicare/Medicaid, Pharmacy, Medical/Disease Research/Clinical Labs, Health Issues
View →
Q1
PERSONALIZED MEDICINE COALITION for PERSONALIZED MEDICINE COALITION
1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate
Budget/Appropriations, Health Issues
View →
Q1
TIBER CREEK GROUP for INCYTE CORPORATION
1st Quarter (Jan 1 - Mar 31) 2026 · Delaware · House · Senate · $80,000.00 income
Medicare/Medicaid
View →
Q1
TIBER CREEK GROUP for EMD SERONO, INC.
1st Quarter (Jan 1 - Mar 31) 2026 · Massachusetts · House · Senate · $50,000.00 income
Health Issues, Medicare/Medicaid
View →
Q1
TIBER CREEK GROUP for ASTRAZENECA
1st Quarter (Jan 1 - Mar 31) 2026 · House · Senate · $80,000.00 income
Medicare/Medicaid, Health Issues
View →
Q1
W STRATEGIES, LLC for INCYTE CORPORATION
1st Quarter (Jan 1 - Mar 31) 2026 · Delaware · House · $60,000.00 income
Health Issues, Medicare/Medicaid
View →
Q1
W STRATEGIES, LLC for CALIFORNIA LIFE SCIENCES
1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · $40,000.00 income
Medicare/Medicaid
View →
Q1
TIBER CREEK GROUP for ALNYLAM PHARMACEUTICALS, INC.
1st Quarter (Jan 1 - Mar 31) 2026 · Massachusetts · House · Senate · $60,000.00 income
Medicare/Medicaid
View →
Q1
LMH STRATEGIC SOLUTIONS for IONIS PHARMACEUTICALS, INC.
1st Quarter (Jan 1 - Mar 31) 2026 · California · House · Senate · $30,000.00 income
Health Issues
View →
Q1
LMH STRATEGIC SOLUTIONS for ALNYLAM PHARMACEUTICALS, INC.
1st Quarter (Jan 1 - Mar 31) 2026 · Massachusetts · House · Senate · $50,000.00 income
Medicare/Medicaid
View →
Q1
LMH STRATEGIC SOLUTIONS for ALKERMES, INC.
1st Quarter (Jan 1 - Mar 31) 2026 · Massachusetts · House · Senate · $60,000.00 income
Medicare/Medicaid
View →
Q1
LUNDBECK LLC for LUNDBECK LLC
1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate
Health Issues, Medicare/Medicaid, Trade (domestic/foreign)
View →
3A
NOVARTIS for NOVARTIS
3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate
Budget/Appropriations, Copyright/Patent/Trademark, Health Issues, Medicare/Medicaid
View →
2A
NOVARTIS for NOVARTIS
2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate
Labor Issues/Antitrust/Workplace, Budget/Appropriations, Copyright/Patent/Trademark, Health Issues
View →
2A
PERSONALIZED MEDICINE COALITION for PERSONALIZED MEDICINE COALITION
2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate
Health Issues, Budget/Appropriations
View →
1A
ALSTON & BIRD LLP for TRAVERE THERAPEUTICS
1st Quarter (Jan 1 - Mar 31) 2025 · California · House · Senate · $60,000.00 income
Health Issues, Medicare/Medicaid, Pharmacy, Medical/Disease Research/Clinical Labs
View →
4A
BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC for BOEHRINGER INGELHEIM USA CORPORATION
4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate
Health Issues, Medicare/Medicaid, Animals, Budget/Appropriations
View →
Q4
TODD STRATEGY GROUP for ALNYLAM PHARMACEUTICALS, INC.
4th Quarter (Oct 1 - Dec 31) 2025 · Massachusetts · House · Senate · $60,000.00 income
Medicare/Medicaid
View →
Q4
TODD STRATEGY GROUP for ASTRAZENECA PHARMACEUTICALS LP
4th Quarter (Oct 1 - Dec 31) 2025 · Delaware · House · Senate · $80,000.00 income
Medicare/Medicaid, Health Issues
View →
Q4
AMERICA'S HEALTH INSURANCE PLANS, INC. (AHIP) for AMERICA'S HEALTH INSURANCE PLANS INC (AHIP)
4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate
Health Issues, Medicare/Medicaid, Insurance, Pharmacy
View →
Q4
EMD SERONO, INC. for EMD SERONO INC
4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate
Veterans, Defense, Copyright/Patent/Trademark, Trade (domestic/foreign)
View →
Q4
GSK (FKA GLAXOSMITHKLINE INC.) for GSK (FKA GLAXOSMITHKLINE INC.)
4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate
Budget/Appropriations, Copyright/Patent/Trademark, Health Issues, Medicare/Medicaid
View →
Q4
SPLITOAK STRATEGIES LLC for JOHNSON & JOHNSON SERVICES, INC.
4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate · $50,000.00 income
Medicare/Medicaid
View →
Previous Page 2 of 11 Next

Source: federal Lobbying Disclosure Act filings. A filing's bill references are parsed from its activity descriptions, so a bill page shows the filings that named it.

Report a problem